COLL COLLEGIUM PHARMACEUTICAL, INC

8-K Current Report

Filed: February 26, 2026

Health Care

Pharmaceutical Preparations

COLLEGIUM PHARMACEUTICAL, INC (COLL) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 7.01: Regulation FD Disclosure
Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year 2025 financial results announced Feb 26, 2026
• Full details in Exhibit 99.1 press release — key figures, guidance, and commentary found there

+1 more insights

Item 7.01 · Regulation FD Disclosure

• Collegium Pharmaceutical (COLL) released an earnings presentation on Feb 26, 2026, covering latest reported period results
• Full details in Exhibit 99.2 — primary source for revenue, earnings, and guidance figures

+1 more insights

Other COLLEGIUM PHARMACEUTICAL, INC 8-K Filings

8-K Mar 19, 2026

Get deeper insights on COLLEGIUM PHARMACEUTICAL, INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.